Reach Us +44-1625-708989
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Antibiotic Resistance in Campylobacter - An Increasing Challenge

Introduction: Campylobacter spp. are the most commonly isolated bacterial agents of acute diarrhoea in the world.

Materials and methods: For 2017, 260 patients were hospitalized with diarrhoea syndrome. Of these, 66 (25.38%) were positive for Campylobacter spp. by cultured and Multiplex PCR. Clinical isolates were tested for susceptibility against 5 antimicrobials.

Results: The isolates of Campylobacter 60 (91%) are C. jejuni and 6 (9%), C. coli. All C. jejuni/coli isolates are Azithromycin (AZI) sensitive, and all C. coli isolates are susceptible to Clarythromycin (CLA) and Erythromycin (ER). Three isolates of C. jejuni (5%) are resistant to CLA and 7 (11.6%) to ER. To Ciprofloxacin (CIP) are resistant 35 (58.3%) of C. jejuni isolates and 2 (33.3%) of C. coli. For Tetracycline (TE) the resistance is 23 (38.3%) for C. jejuni and 1 (16.6%) for C. coli, respectively. In C. jejuni there were 3 multiresistant isolates (5%) to CIP-CL-ER-TE simultaneously; also 3 (5%) to CL-ER-CIP and 7 (11.6%) to TE-ER. In C. coli there was 1 (16.6%) TEER-resistant isolate.

Discussion: Increased resistance of Campylobacter spp. to the most commonly used antimicrobial agents has been observed. Particularly worrying is the high resistance to Ciprofloxacin, as well as the increasingly common multi-drug resistant isolates.


Author(s): Velev V, Pavlova M, Ivanov IN, Mangarov A and Kantardjivev T

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+